Clinical Trial Update: Integrated Imaging System for In Vivo Visualization of Free Flap Perfusion Using Indocyanine Dye [NA]

View source ↗

Summary

A clinical trial evaluating an integrated imaging system with indocyanine dye for visualizing free flap perfusion in breast reconstruction has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Indocyanine Green (Indocyanine Green)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Breast Reconstruction | NA | Status: WITHDRAWN